Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Female Sexual Desire Drugs
Dutch company Emotional Brain has come out with two drugs that are currently in clinical trials—Lybrido and Lybridos—for women suffering from hypoactive sexual desire disorder (HSDD). The drugs reportedly can increase women’s central sexual motivation, which apparently can flag for some women after years of being in a monogamous relationship. Would you take such a drug?